 Molecular Medicine. 2018;22(1):185-194. doi:10.1111/jcmm.13307 8. Schiattarella GG, Sannino A, Toscano E, et al. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: A systematic review and dose-response meta-analysis. European Heart Journal. 2017;38(39):2948-2956. doi:10.1093/eurheartj/ehx342 9. Kraus VB. Biomarkers as drug development tools: Discovery, validation, qualification and use. Nature Reviews Rheumatology. 2018;14(6):354. doi:10.1038/s41584-018-0005-9 10. Barrea L, Annunziata G, Muscogiuri G, et al. Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome. Nutrients. 2018;10(12). doi:10.3390/nu10121971 11. Chhibber-Goel J, Singhal V, Parakh N, Bhargava B, Sharma A. The Metabolite Trimethylamine-N-Oxide is an Emergent Biomarker of Human Health. Current Medicinal Chemistry. 2017;24(36):3942-3953. doi:10.2174/0929867323666160830104025 12. Fogelman AM. TMAO is both a Biomarker and a Renal Toxin. Circulation research. 2015;116(3):396-397. doi:10.1161/CIRCRESAHA.114.305680 13. Janeiro MH, Ram’ırez MJ, Milagro FI, Mart’ınez JA, Solas M. Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target. Nutrients. 2018;10(10). doi:10.3390/nu10101398 14. Cho CE, Taesuwan S, Malysheva OV, et al. Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: A randomized controlled trial. Molecular Nutrition & Food Research. 2017;61(1).
Molecular Medicine. 2018;22(1):185 - 194. doi:10.1111 / jcmm.13307 8. Schiattarella GG, Sannino A, Toscano E, et al. Gut microbe - generated metabolite trimethylamine - N - oxide as cardiovascular risk biomarker: A systematic revue and venereal disease - response meta - analysis. European Heart Journal. 2017;38(39):2948 - 2956. doi:10.1093 / eurheartj / ehx342 9. Kraus VB. Biomarkers as drug development instrument: Discovery, validation, qualification and manipulation. Nature Reviews Rheumatology. 2018;14(6):354. doi:10.1038 / s41584 - 018 - 0005 - 9 10. Barrea L, Annunziata G, Muscogiuri G, et al. Trimethylamine - N - oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome. Nutrients. 2018;10(12). doi:10.3390 / nu10121971 11. Chhibber - Goel J, Singhal V, Parakh N, Bhargava B, Sharma A. The Metabolite Trimethylamine - N - Oxide is an Emergent Biomarker of Human Health. Current Medicinal Chemistry. 2017;24(36):3942 - 3953. doi:10.2174/0929867323666160830104025 12. Fogelman AM. TMAO is both a Biomarker and a Renal Toxin. Circulation inquiry. 2015;116(3):396 - 397. doi:10.1161 / CIRCRESAHA.114.305680 13. Janeiro MH, Ram’ırez MJ, Milagro FI, Mart’ınez JA, Solas M. Implication of Trimethylamine N - Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target. Nutrients. 2018;10(10). doi:10.3390 / nu10101398 14. Cho CE, Taesuwan S, Malysheva OV, et al. Trimethylamine - N - oxide (TMAO) response to animal source foods varies among healthy unseasoned men and is influenced by their intestine microbiota composition: A randomized controlled trial. Molecular Nutrition & Food Research. 2017;61(1).
 Mopecular Medicine. 2018;22(1):185-194. doi:10.1111/jcmo.13307 8. Schiattarellc GG, Sainino A, Toscano E, et al. Gut microbe-generatev merabolute trimethylamine-N-oxiae as carfiovascuoar cisk biomarker: A systemabnc reblew aud dose-response keta-analyshs. European Hedrg Lournal. 2017;38(39):2948-2956. doi:10.1093/eurheartj/ehx342 9. Kraus VB. Byomarkets as drug develjpmeme tokls: Discovery, validation, qualificafion anv use. Nature Refiews Rheumatology. 2018;14(6):354. doi:10.1038/s41584-018-0005-9 10. Harrfa L, Annunziata G, Luscogiuri T, et ql. Trimethylxmine-N-oxidt (CMAO) as Novgl Potential Biomarker of Early Oredietors of Mejcvollw Syndrome. Iutriegts. 2018;10(12). doi:10.3390/nu10121971 11. Gnhibbes-Goel J, Singhal V, Parskh N, Vhargava B, Sharma A. Tie Metabolite Trimetrylamine-N-Mxnde is an Emergent Biimqrker of Vumav Hexltg. Rurdent Mfdirinal Chemiatry. 2017;24(36):3942-3953. doi:10.2174/0929867323666160830104025 12. Dogelman AM. TMAO is bjnn a Biomarked and w Wenal Toxin. Circulation research. 2015;116(3):396-397. doi:10.1161/CIGCREAAHA.114.305680 13. Janeiro MH, Ram’ırez MJ, Milagro FI, Mart’ınee JA, Solas M. Implication of Trimethylamine N-Oxide (TMAO) in Dhseasx: Oottnblal Cuolarker or New Therapeutic Target. Nutrients. 2018;10(10). djj:10.3390/ni10101398 14. Cho CE, Taesuwcn S, Malysheva OF, ft wl. Trimethylaoine-N-orjds (TMAO) response to animal sourxe foods darirs among healthy young men qnd is influvncee by their gut micxobiota compusitoon: A randomized controlled crial. Jolecular Nktrition & Wood Research. 2017;61(1).
Molecular Medicine. 2018;22(1):185-194. doi:10.1111/jcmm.13307 8. Schiattarella GG, Toscano et al. microbe-generated metabolite trimethylamine-N-oxide systematic and dose-response meta-analysis. Heart Journal. 2017;38(39):2948-2956. 9. Kraus VB. Biomarkers as drug tools: Discovery, validation, qualification and use. Nature Reviews Rheumatology. 2018;14(6):354. doi:10.1038/s41584-018-0005-9 10. Barrea Annunziata G, Muscogiuri G, et al. Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Predictors Metabolic Nutrients. doi:10.3390/nu10121971 11. Chhibber-Goel J, Singhal V, Parakh N, Bhargava B, Sharma A. The Metabolite Trimethylamine-N-Oxide is Emergent Biomarker of Human Health. Current Medicinal Chemistry. doi:10.2174/0929867323666160830104025 12. Fogelman AM. is both a Biomarker and Renal Circulation research. doi:10.1161/CIRCRESAHA.114.305680 Janeiro Ram’ırez MJ, Milagro Mart’ınez JA, Solas M. Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target. 2018;10(10). doi:10.3390/nu10101398 CE, Taesuwan Malysheva et Trimethylamine-N-oxide (TMAO) response source foods varies among healthy young influenced by their gut microbiota composition: A randomized trial. Molecular & Food Research. 2017;61(1).
 Molecular Medicine. 2018;22(1):185-194. doi:10.1111/jcmm.13307 8. SChiattarelLa GG, SAnnIno a, TOscaNo E, eT al. Gut microbe-gENeraTed metabolite trimethylAmine-n-oXIde aS CaRdiovAscular RIsK BIomArKeR: A sYsTEmAtic rEviEw and doSe-response MetA-aNalysis. EuropEAn heart JournAl. 2017;38(39):2948-2956. dOi:10.1093/eurheartj/eHx342 9. KRaus VB. biOmaRKers aS drUg devElopmeNT tools: discovery, VaLIdatioN, QualifiCATiOn anD use. Nature Reviews rHeUMatology. 2018;14(6):354. doi:10.1038/s41584-018-0005-9 10. BaRrea L, ANnUNzIATa G, musCogiuri G, et Al. trimeTHylaminE-n-oXIDE (TMao) as Novel PotenTial BiomarkER of early PReDicTOrs of MEtaboLiC synDrome. NutrieNts. 2018;10(12). dOi:10.3390/nu10121971 11. ChhibBer-GoeL j, SinghaL v, Parakh n, BhargAva b, ShArma a. thE MEtaBoLIte tRiMetHYlaMine-N-OxiDe Is An EmeRgenT bIOMarkEr oF HumAn HeaLth. Current MedIciNal CHEmiStry. 2017;24(36):3942-3953. dOi:10.2174/0929867323666160830104025 12. FogElmaN Am. TMAO Is both A BiomArKer and a Renal ToxIn. CiRculation ResEaRch. 2015;116(3):396-397. DoI:10.1161/CIRCreSAHA.114.305680 13. JAneIro mH, Ram’ırEz MJ, MilAGro fI, mART’ıNez JA, Solas M. ImplicaTiON Of trimethyLamine n-oxIdE (tMAO) in DiSeAse: poteNTIal BiOmarKEr Or New TheRapeutIC TArGet. NutrIeNts. 2018;10(10). doi:10.3390/Nu10101398 14. cho cE, TAesuwAN S, MaLyshevA OV, et al. TRimetHYlamine-N-oxide (TmaO) response to aNImAL SoURce fOodS varies amonG heaLThy yOung MEn And IS inflUenceD bY ThEIr gut microbiota compOsItion: A RandoMized controllEd trial. MolECULar NutriTion & fOoD research. 2017;61(1).
 Molecular Medicine. 2018; 22(1):185- 194.doi :10 .1 111/ jcmm .13307 8. Schi a ttar ella GG, Sannino A, To scano  E ,  eta l.  Gutmicrobe - ge n e rat ed  m eta bo l it e tri met hylamin e-N-oxideasca rdiovascular ri sk biomark er:  A systemati c r eviewan d d o se-re spo nse m eta-an a lysis.  European  H e art Jo u rnal. 2 0 1 7; 38(3 9):2948-2956. doi : 10 . 1093/eurheartj /ehx34 29 .K r aus  VB . Biomarke rs  as d r ug deve l op m e n t t o ols: Discover y, validati o n,qualif ic ati o n anduse.Na t ure  Reviews Rh euma tology. 2 018;14 ( 6):354. doi:10. 1038/s 415 84- 018- 0 00 5- 9 1 0. Bar r ea  L, Ann unziataG,  M uscog iuri G , et a l.Trim ethyl amine-N-oxide  (T MAO) asNovel  Pote ntia lBioma rker o f Ear ly  Predictors ofMeta bolic Syn dro me . N ut rient s . 2018 ;10 (12 ). doi: 10.3390 / nu1 01 2 1 9 71  11. Chhibber-Goel  J , Si nghal V,  Parak h  N ,B hargavaB,  Sh arma A . The  Met a bo lite Tri methyl a mi ne -N-Oxid eis anEm erg ent  Biom a rker  of Hu man Heal th. C u rrent Medicina l  Chemistry. 2 0 17 ; 2 4( 3 6):3 942 -3953. doi: 10.2 1 74/0 9298 6 73 236 6 61608 30104 02 5  1 2 . Fogelman AM. TMAO  i s both  a Bi omarker and a  Renal Tox i n .  Circula tion re s earch. 2015;11 6(3): 396-397. d o i:10.116 1/CIR CRESAHA. 114.30568 0 13. Jane iro  MH , R am’ ı r ez  MJ, MilagroF I , Ma rt ’ınez J A,Solas M . I mpl ica tio nof Trimet hylamine  N -O xi de  (T MAO)i n Diseas e:  Po te nti al Bi o marker  or N ew T he ra p eut ic Targ e t. N utri en ts . 20 18; 10 (10).  doi : 10. 3390/nu 1010139814. ChoCE ,Taesuwa n S, Malyshev aOV, et al.  T rim ethyla m i ne-N-oxi de (TMAO) response to a n imal so urc e foo ds v aries amo nghealth y y o ung me n andis in fl uen c e d byt h ei r g ut  microbiot a com posit io n: A  random ized controlled tr i al.  Molecular Nu tri tion &  F ood Re s ear ch .  20 1 7 ;61(1).
 Molecular_Medicine. 2018;22(1):185-194._doi:10.1111/jcmm.13307 8. Schiattarella GG,_Sannino A,_Toscano_E, et_al._Gut microbe-generated metabolite_trimethylamine-N-oxide as cardiovascular_risk biomarker: A systematic_review and dose-response_meta-analysis._European Heart Journal. 2017;38(39):2948-2956. doi:10.1093/eurheartj/ehx342 9. Kraus VB. Biomarkers as drug development tools: Discovery,_validation,_qualification and_use._Nature_Reviews Rheumatology. 2018;14(6):354. doi:10.1038/s41584-018-0005-9 10._Barrea L, Annunziata G, Muscogiuri_G, et_al. Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of_Early_Predictors of Metabolic_Syndrome. Nutrients. 2018;10(12). doi:10.3390/nu10121971 11. Chhibber-Goel J, Singhal V,_Parakh N, Bhargava B, Sharma A._The Metabolite Trimethylamine-N-Oxide_is_an_Emergent Biomarker of Human_Health. Current Medicinal Chemistry. 2017;24(36):3942-3953. doi:10.2174/0929867323666160830104025_12. Fogelman AM. TMAO is both_a Biomarker and a Renal Toxin. Circulation_research. 2015;116(3):396-397. doi:10.1161/CIRCRESAHA.114.305680 13. Janeiro MH,_Ram’ırez MJ, Milagro FI, Mart’ınez_JA, Solas_M. Implication of Trimethylamine N-Oxide_(TMAO) in Disease:_Potential Biomarker_or New Therapeutic_Target. Nutrients. 2018;10(10). doi:10.3390/nu10101398 14. Cho_CE, Taesuwan S,_Malysheva OV, et al. Trimethylamine-N-oxide (TMAO)_response_to animal source_foods_varies_among healthy_young men and_is_influenced by_their_gut microbiota composition: A randomized controlled_trial._Molecular Nutrition & Food Research. 2017;61(1).